316 related articles for article (PubMed ID: 7850796)
21. Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis.
Stürzl M; Brandstetter H; Zietz C; Eisenburg B; Raivich G; Gearing DP; Brockmeyer NH; Hofschneider PH
Oncogene; 1995 May; 10(10):2007-16. PubMed ID: 7761101
[TBL] [Abstract][Full Text] [Related]
22. Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness.
Thompson EW; Nakamura S; Shima TB; Melchiori A; Martin GR; Salahuddin SZ; Gallo RC; Albini A
Cancer Res; 1991 May; 51(10):2670-6. PubMed ID: 2021945
[TBL] [Abstract][Full Text] [Related]
23. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
[TBL] [Abstract][Full Text] [Related]
24. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells.
Abemayor E
Laryngoscope; 1992 Oct; 102(10):1133-49. PubMed ID: 1328787
[TBL] [Abstract][Full Text] [Related]
25. Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk.
Cassoni P; Sapino A; Deaglio S; Bussolati B; Volante M; Munaron L; Albini A; Torrisi A; Bussolati G
Cancer Res; 2002 Apr; 62(8):2406-13. PubMed ID: 11956104
[TBL] [Abstract][Full Text] [Related]
26. High retinoid X receptor expression in JEG-3 choriocarcinoma cells: involvement in cell function modulation by retinoids.
Guibourdenche J; Roulier S; Rochette-Egly C; Evain-Brion D
J Cell Physiol; 1998 Sep; 176(3):595-601. PubMed ID: 9699512
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-4 receptor expression in vivo on human AIDS-related Kaposi's sarcoma.
Varricchio F; Husain SR; Leland P; Gill P; Puri RK
Oncol Res; 1997; 9(9):495-503. PubMed ID: 9495455
[TBL] [Abstract][Full Text] [Related]
28. Induction of IL-6 gene expression in Kaposi's sarcoma cells.
Yang J; Hagan MK; Offermann MK
J Immunol; 1994 Jan; 152(2):943-55. PubMed ID: 8283061
[TBL] [Abstract][Full Text] [Related]
29. Consensus-interferon and platelet-derived growth factor adversely regulate proliferation and migration of Kaposi's sarcoma cells by control of c-myc expression.
Köster R; Blatt LM; Streubert M; Zietz C; Hermeking H; Brysch W; Stürzl M
Am J Pathol; 1996 Dec; 149(6):1871-85. PubMed ID: 8952524
[TBL] [Abstract][Full Text] [Related]
30. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
31. Different combinations of retinoids and vitamin D3 analogs efficiently promote growth inhibition and differentiation of myelomonocytic leukemia cell lines.
Defacque H; Dornand J; Commes T; Cabane S; Sevilla C; Marti J
J Pharmacol Exp Ther; 1994 Oct; 271(1):193-9. PubMed ID: 7965714
[TBL] [Abstract][Full Text] [Related]
32. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation.
Lotan R; Dawson MI; Zou CC; Jong L; Lotan D; Zou CP
Cancer Res; 1995 Jan; 55(2):232-6. PubMed ID: 7812950
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis of AIDS-associated Kaposi's sarcoma.
Ensoli B; Barillari G; Gallo RC
Hematol Oncol Clin North Am; 1991 Apr; 5(2):281-95. PubMed ID: 2022594
[TBL] [Abstract][Full Text] [Related]
34. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
Le Q; Dawson MI; Soprano DR; Soprano KJ
Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
[TBL] [Abstract][Full Text] [Related]
35. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma.
Cai J; Gill PS; Masood R; Chandrasoma P; Jung B; Law RE; Radka SF
Am J Pathol; 1994 Jul; 145(1):74-9. PubMed ID: 8030759
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of melanotic expression in cultured mouse melanoma cells by retinoids.
Lotan R; Lotan D
J Cell Physiol; 1981 Feb; 106(2):179-89. PubMed ID: 6260817
[TBL] [Abstract][Full Text] [Related]
37. Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth.
Amaral MC; Miles S; Kumar G; Nel AE
J Clin Invest; 1993 Aug; 92(2):848-57. PubMed ID: 7688764
[TBL] [Abstract][Full Text] [Related]
38. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells.
Miles SA; Martínez-Maza O; Rezai A; Magpantay L; Kishimoto T; Nakamura S; Radka SF; Linsley PS
Science; 1992 Mar; 255(5050):1432-4. PubMed ID: 1542793
[TBL] [Abstract][Full Text] [Related]
39. Effects of retinoic acid versus dimethyl sulfoxide on Friend erythroleukemia cell growth. I. Cell proliferation, RNA content, and protein content.
Traganos F; Bueti C; Darzynkiewicz Z; Melamed MR
J Natl Cancer Inst; 1984 Jul; 73(1):193-204. PubMed ID: 6588224
[TBL] [Abstract][Full Text] [Related]
40. All-trans-retinoic acid inhibits the growth of human rhabdomyosarcoma cell lines.
Crouch GD; Helman LJ
Cancer Res; 1991 Sep; 51(18):4882-7. PubMed ID: 1893378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
